Skip to main content
SpringerLink
Log in

Sedative-Hypnotic Dependence

  • Chapter
  • First Online:
Substance Use Disorders

Abstract

In addition to alcohol, drugs that depress the central nervous system include barbiturates, benzodiazepines, insomnia medications collectively referred to as the Z drugs, gamma-hydroxybutyric acid (GHB), a group of medications primarily of historical interest, meprobamate, and chloral hydrate. These drugs are used mainly to calm and relax patients (sedatives or anxiolytics) or to induce sleep (hypnotics). Collectively, they are known as sedative-hypnotics.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Barbiturate statistics. Erowid.org website. http://www.erowid.org/chemicals/barbiturates/barbiturates_stats.shtml

  2. Cohen S. The barbiturates: has their time gone? In: The substance abuse problems: volume one. New York: Haworth Press; 1981. p. 119–24.

    Google Scholar 

  3. Mandal Ananya. Barbiturate history website. www.news-medical.net/health/Barbiturate-History.aspx. May 26, 2013.

  4. O’Brien R, Barbiturates CS. The encyclopedia of drug abuse. New York: Facts on File; 1984. p. 35–8.

    Google Scholar 

  5. Milhorn HT. Chemical dependence: diagnosis, treatment, and prevention. New York: Springer; 1990.

    Book  Google Scholar 

  6. Allgulander C. Barbiturates. In: Encyclopedia of psychopharmacology. Heidelberg/New York: Springer; 2014.

    Google Scholar 

  7. Denno DW. Gas chamber: execution device. Encycloepedia Britannica. February 9, 2012.

    Google Scholar 

  8. Olsen RW, Yang J, King RG, Dilber A, Stauber GB, Ransom RW. Barbiturate and benzodiazepine modulation of GABA receptor binding and function. Life Sci. 1986;39(21):1969–76.

    Article  CAS  PubMed  Google Scholar 

  9. Harvey S. Hypnotics and sedatives. In: Goodman LS, Gilman AG, Rall TW, Murad F, editors. Goodman and Gilman’s the pharmacological basis of therapeutics. New York: Macmillan; 1985. p. 339–69.

    Google Scholar 

  10. Trevor AJ. Sedative-hypnotic drugs. In: Katzung BG, Trevor AJ, editors. Basic and clinical pharmacology. 13th ed. New York: McGraw-Hill Education; 2015. p. 369–83.

    Google Scholar 

  11. Heller JL. Barbiturate intoxication and overdose. MedlinePlus website. https://medlineplus.gov/ency/article/000951.htm. U.S. National Library of Medicine. October 9, 2015.

  12. Lafferty KA. Barbiturate toxicity. Medscape website. http://emedicine.medscape.com/article/813155-overview. January 14, 2017.

  13. Trevor AJ, Way WL. Sedative-hypnotics. In: Katzung BG, editor. Basic and clinical Pharmacology. Norwalk: Appleton and Lange; 1987. p. 241–53.

    Google Scholar 

  14. Barbiturates withdrawal symptoms & treatment. Pat Moore Foundation website. http://www.patmoorefoundation.com/barbiturates-withdrawal-symptoms-treatment

  15. Longo LP, Brian J. Addiction: part I. Benzodiazepines – side effects, abuse risk and alternatives. Am Fam Physician. 2000;61(7):2121–8.

    CAS  PubMed  Google Scholar 

  16. Lader M. History of benzodiazepine dependence. J Subst Abus Treat. 1991;8:53–9.

    Article  CAS  Google Scholar 

  17. Laux G, Puryear DA. Benzodiazepines – misuse, abuse and dependency. Am Fam Physician. 1984;30(5):139–47.

    CAS  PubMed  Google Scholar 

  18. Benzodiazepines: list of trade names, uses and dosage. UATests.com website. http://www.uatests.com/drug-information/benzodiazepines-list.php

  19. Dubuc B. The brain from top to bottom. McGill University. http://thebrain.mcgill.ca. May 2012.

  20. Benzodiazepines: overview and use. Drugs.com website. http://www.drugs.com/article/benzodiazepines.html. May 04, 2014.

  21. West LM. Benzodiazepines: benefits versus risks. J Malta Coll Pharm Pract 2007;(Summer):13.

    Google Scholar 

  22. Benzodiazepines. NSW government, Health website. http://www.health.nsw.gov.au/mentalhealth/Factsheets/Pages/benzodiazepines.aspx. July 11, 2013.

  23. Benzodiazepine abuse. WebMD website. http://www.webmd.com/mental-health/addiction/benzodiazepine-abuse#1

  24. Smith DE, Wesson DR. Benzodiazepine withdrawal syndromes. J Psychoactive Drugs. 1983;15:85–95.

    Article  CAS  PubMed  Google Scholar 

  25. Benzodiazepine & ‘z’ drugs withdrawal protocol. NHS Northamptonshire website. http://www.neneccg.nhs.uk/resources/uploads/files/benzodiazepine_protocol.pdf

  26. Ashton CBH. Comparison chart. Pharmer.org website. http://m.pharmer.org/forum/discussion-prescription-and-otc-meds/benzo-comparison-chart . April 2007.

  27. Gresham C. Benzodiazepine toxicity. Medscape website. http://emedicine.medscape.com/article/813255-overview. April 29, 2016.

  28. Flumazenil dosage. Drugs.com website. http://www.drugs.com/dosage/flumazenil.html

  29. Flunitrazepam (Rohypnol). Center for Substance Abuse Research (CESAR) at the University of Maryland website. http://www.cesar.umd.edu/cesar/drugs/rohypnol.pdf

  30. Date rape drugs fact sheet. Office on women’s health in the office of the assistant secretary for health at the U.S. Department of health and human services website. http://www.womenshealth.gov/publications/our-publications/fact-sheet/date-rape-drugs.html. July 16, 2012.

  31. Gahlinger PM. Club drugs: MDMA, Gamma-Hydroxybutyrate (GHB), Rohypnol, and Ketamine. Am Fam Physician. 2004;69(11):2619–27.

    PubMed  Google Scholar 

  32. Insomnia treatment with non-benzodiazepines Ambien, Lunesta & Sonata. Drugs.com website. http://www.drugs.com/slideshow/insomnia-treatment-nonbenzodiazepines-1072. April 5, 2016.

  33. Gunja N. The clinical and forensic toxicology of z-drugs. J Med Toxicol. 2013;9(2):155–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Tamura L. Z drugs keep sleep-aid market awake. Washington Post. February 15, 2011.

    Google Scholar 

  35. GHB. Center for Substance Abuse Research (CESAR) at the University of Maryland website. http://www.cesar.umd.edu/cesar/drugs/ghb.pdf

  36. GHB or Gamma-Hydroxybutyrate. Drugs.com website. http://www.drugs.com/illicit/ghb.html

  37. O’Connell T, Kaye L, Plosay JJ III. Gamma-Hydroxybutyrate (GHB): a newer drug of abuse. Am Fam Physician. 2000;62(11):2478–82.

    PubMed  Google Scholar 

  38. Gamma Hydroxybutyrate (GHB). Office of National Drug Control Policy website. http://www.ncjrs.gov/pdffiles1/Digitization/194881NCJRS.pdf

  39. What is GHB? Project GHB website. http://www.projectghb.org/content/what-ghb

  40. Benzer T. Gamma-Hydroxybutyrate toxicity treatment & management. Medscape website. http://emedicine.medscape.com/article/820531-treatment. December 29, 2015.

  41. Wilford BB. Sub-acute care. In: Review course syllabus. New York: American Medical Society on Alcohol and Other Drug Dependencies; 1987. p. 189–218.

    Google Scholar 

  42. Milhorn HT. Pharmacologic management of acute abstinence syndromes – withdrawal symptoms. Am Fam Physician. 1992;45(1):231–9.

    PubMed  Google Scholar 

  43. Gwilt PR, Pankaskie MD, Zustiak R, Shoenthal DR. Pharmacokinetics of methyprylon following a single oral dose. J Pharm Sci. 1985;74:1001–3.

    Article  CAS  PubMed  Google Scholar 

  44. Hasson E. Treatment of meprobamate overdose with repeated oral doses of activated charcoal. Ann Emerg Med. 1986;15:73–6.

    Article  Google Scholar 

  45. Carisoprodol. MedLibrary.org website. http://medlibrary.org/medwiki/Carisoprodol. June 22, 2001.

  46. Mohammed MS, Aquino MF. The use of chloral hydrate in pediatric electroencephalography. Neurosciences. 2001;6(2):99–102.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. East Central HealthNet Family Medicine Residency Program, Meridian, Mississippi, USA

    H. Thomas Milhorn MD, PhD (Director, Didactics Section, Formerly Professor of Family Medicine, Professor of Physiology and Biophysics, and Associate Professor of Psychiatry and Human Behavior)

  2. University of Mississippi School of Medicine, Jackson, Mississippi, USA

    H. Thomas Milhorn MD, PhD (Director, Didactics Section, Formerly Professor of Family Medicine, Professor of Physiology and Biophysics, and Associate Professor of Psychiatry and Human Behavior)

Authors
  1. H. Thomas Milhorn MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Milhorn, H.T. (2018). Sedative-Hypnotic Dependence. In: Substance Use Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-63040-3_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-63040-3_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-63039-7

  • Online ISBN: 978-3-319-63040-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation